Pure Global
NCT03467737

Assessment of Starch Digestibility and Amylase Sufficiency in Children

Assessing Malian and U.S. Children for Starch Digestion and Amylase Sufficiency and Identifying Better Energy Providing Foods for Growth and Recovery
Purdue University·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Malnutrition, Child
Drug/Device/Intervention
Normal sorghum porridge, algal starch
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Purdue University
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2012
End date
Jul 01, 2016
Enrollment
54 participants
Primary outcome

Alpha-amylase sufficiency in children,Starch digestibility,Gastric emptying

Summary

Research has demonstrated that there is a relationship between malnourishment and
 insufficient production of pancreatic enzymes, such as α-amylase which digests starch into
 glucose. Starchy foods that can be easily digested into glucose are critical to the
 development child for energy and proper growth. This study investigated the use of a
 noninvasive breath test for the assessment of amylase sufficiency, digestibility of normal
 and modified sorghum porridges and gastric emptying rate of a sorghum porridge in Malian and
 U.S. children.

ICD-10 classifications
MalnutritionMalnutrition in pregnancySequelae of malnutrition and other nutritional deficienciesMalnutrition-related diabetes mellitusMalnutrition-related diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT03467737
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT03467737 through Pure Global AI's free database. This phase not specified trial is sponsored by Purdue University and is currently Completed. The study focuses on Malnutrition, Child. Target enrollment is 54 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.